During Two-Year Personal Study, Doctor Watches Himself Get Diabetes In Close Detail
Personal Omics The integrative personal omics profile took several tissue samples and required various types of analysis. CellA milestone in personalized medicine For more than two years, Stanford University geneticist Michael Snyder donated his living body to science. He and fellow researchers examined his DNA, RNA, proteins and metabolites, creating an incredibly detailed profile of his personal "omics." They watched in real time and at the molecular level as viruses attacked his cells, and they figured out, to their shock, that he was prone to developing type 2 diabetes. And then they watched him develop it. It's the first study to follow the molecular processes of sickness and health in one individual, and as such it's a major breakthrough for personalized medicine. It's also the first real-time view of the birth of a disease that afflicts millions of people, according to Stanford University Medical Center. Since the earliest days of...